We're currently leaning towards a bullish melt-up scenario into August 2025, supported by both price structure and Gann time analysis.
🔹 Key Gann Time Clusters:
11th July 2025
14th July 2025
These dates may act as pivotal turning points. The ideal scenario for bulls would be a short-term pullback into the 15th–16th July window, which could then confirm the next major leg up.
📈 Price action is riding strongly above the 1/1 and 2/1 Gann angles – a clear sign of accumulation and strength. The setup aligns well with a continued rally targeting August 2025 as a significant cycle top before any serious correction unfolds.
🎯 Watch the coming days closely. If we get a healthy dip, it may be your best buy-the-dip opportunity ahead of a major move.
🔹 Key Gann Time Clusters:
11th July 2025
14th July 2025
These dates may act as pivotal turning points. The ideal scenario for bulls would be a short-term pullback into the 15th–16th July window, which could then confirm the next major leg up.
📈 Price action is riding strongly above the 1/1 and 2/1 Gann angles – a clear sign of accumulation and strength. The setup aligns well with a continued rally targeting August 2025 as a significant cycle top before any serious correction unfolds.
🎯 Watch the coming days closely. If we get a healthy dip, it may be your best buy-the-dip opportunity ahead of a major move.
Read the full article on our website: vitaldirection.co.uk/analysis/
Join our FREE Telegram community (3k Members): t.me/vitaldirectiongroup
Join our FREE Telegram community (3k Members): t.me/vitaldirectiongroup
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Read the full article on our website: vitaldirection.co.uk/analysis/
Join our FREE Telegram community (3k Members): t.me/vitaldirectiongroup
Join our FREE Telegram community (3k Members): t.me/vitaldirectiongroup
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.